SLC35B4 and prostate carcinoma: Using a combination of different in vivo and in vitro assays, we demonstrated that SLC35B4 expression was increased in prostate cancer tissues and that silencing SLC35B4 expression suppressed cancer cell proliferation, migration and invasion.